VHA Data Helps Validate Tool for Hypoglycemia Risk ID

by U.S. Medicine

February 8, 2018

OAKLAND, CA—Data from more than 1.3 million VHA patients was used to help validate a practical tool for identifying people with diabetes who are at the highest risk for being admitted to an emergency department or hospital due to severe hypoglycemia.

Also used to confirm the effectiveness of the tool was information from nearly 15,000 Kaiser Permanente members in Washington state with Type 2 diabetes, according to the report JAMA Internal Medicine.1

“Sometimes a person with diabetes is unaware that their blood sugar is dropping and can progress quickly into severe hypoglycemia, which has been associated with falls, automobile accidents, heart attacks, coma and even death,” explained lead author Andrew J. Karter, PhD, senior research scientist with the Kaiser Permanente Division of Research. “Hypoglycemia is often preventable with the proper clinical attention, and we believe this tool will help focus that attention on the patients who most need it.”

Hypoglycemia accounts for an estimated 100,000 adverse events resulting in emergency department (ED) visits each year in the United States, making it one of the most frequent adverse events in patients with Type 2 diabetes. Especially susceptible, according to Karter, are older patients and those with a longer history of diabetes.

The hypoglycemia risk stratification tool was developed by identifying 156 possible risk factors for hypoglycemia and collecting data from more than 200,000 patients with type 2 diabetes receiving care from Kaiser Permanente in Northern California. The information was analyzed, and a model was created to predict a patient’s 12-month risk of hypoglycemia-related ED or hospital use.

Six variables made up the final model:

  • number of prior episodes of hypoglycemia-related emergency department visits or hospitalizations;
  • use of insulin;
  • use of sulfonylurea;
  • severe or end-stage kidney disease;
  • number of emergency room visits for any reason in the past year; and age

Development of the tool was funded by the Food and Drug Administration (FDA) under the Safe Use Initiative, a collaborative effort to reduce adverse events related to medication use, including diabetes medications linked to an increased risk of hypoglycemia. The results are being disseminated with help from the Centers for Medicare and Medicaid Services (CMS).

  1. Karter AJ, Warton EM, Lipska KJ, Ralston JD, Moffet HH, Jackson GG, Huang ES, Miller DR. Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital Use. JAMA Intern Med. 2017 Oct 1;177(10):1461-1470. doi: 10.1001/jamainternmed.2017.3844. PubMed PMID: 28828479; PubMed Central PMCID

Related Articles

Despite Unanimous House Support, VA Opposes ‘Blue Water’ Legislation

VA officials told lawmakers last month that it opposes a bill that would expand the presumption of Agent Orange exposure to Vietnam veterans who served offshore because the "science is not there."

VA Launches Study to Address Liver Fluke/Bile Duct Cancer Concerns

A recently launched VA study of mortality in Vietnam veterans will examine whether exposure to liver flukes, a parasitic worm, increased the risk of cholangiocarcinoma or bile duct cancer in those veterans.

U.S. Medicine Recommends

More From diabetes


Cautious Use of Prandial Insulin Urged for Older Veterans

A new VA study pointed out why prandial insulin should be used cautiously in older adults with complex comorbidities.


Adherence to New Medications Is Critical for Veterans With Diabetes

How important is adherence to oral medications in reducing complications for veterans with diabetes?


VA Research Links Global Air Pollution to Diabetes Risk

Air pollution, even at levels technically falling into safe ranges, are associated with an increased risk of diabetes, according to a new study involving VA researchers.


Preventing, Treating Diabetic Foot Ulcers Are Complex Challenges at VA

Some of the risks of diabetic foot ulcers (DFUs) are well-known, including infection and, in the most severe cases, amputation.


Evidence of CV Benefit Influences Diabetes Treatment Recommendations

In a significant change, the American Diabetes Association’s 2018 guidelines advocate use of a glucose-lowering agent with proven cardiovascular benefit or mortality reduction in patients with Type 2 diabetes mellitus (T2DM) and co-morbid cardiovascular disease.

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up